MANAGEMENT TEAM

The NeuroVista management team has a proven track-record of developing and commercializing innovative medical technologies that have a profound impact on healthcare. Unique domain expertise in the design and development of implantable neurological products, combined with a passion to improve the lives of people with debilitating conditions, has compelled this accomplished team to pursue the development of revolutionary technologies for the management and treatment of epilepsy.

Mary K. Moore
VICE PRESIDENT OF REGULATORY AFFAIRS

Mary K. MooreMary K. Moore is NeuroVista’s Vice President of Regulatory Affairs and brings more than 20 years of regulatory affairs and quality assurance experience in the medical device industry. Mary is responsible for the development and execution of the Company’s regulatory strategy and for interfacing with regulatory agencies in the development and commercialization of NeuroVista’s technologies.

Prior to joining NeuroVista, Mary held a variety of leadership positions in early-stage medical device companies. Most recently, Mary was Vice President of Regulatory Affairs and Quality Assurance at Cardiac Dimensions®, Inc., a startup company in Kirkland, WA developing a permanent class III implant for minimally invasive treatment of congestive heart failure. She was previously Vice President, Regulatory and Government Affairs and Quality Assurance at BD Technologies (formerly TriPath Imaging Inc.), a company that develops cancer diagnostic and molecular screening products. Mary also has held senior management positions at Bioject, Advanced Technology Laboratories (now Philips Medical Systems) and Siemens Medical Systems.

Mary received a BS in biology from Gonzaga University and a MS in bioengineering from the University of Washington.

MEET OUR TEAM